LEXT.CN · 2022-05-13 12:00:00

Director's approve five to one share consolidation

Corporate Actions

929 Mainland Street

Vancouver, BC V6B 1S3

Phone

Fax

(604) 928-8913

(604) 628-0129

Website www.lexston.ca

NEWS RELEASE

LEXSTON’S DIRECTORS APPROVE FIVE TO ONE SHARE CONSOLITDATION

Vancouver, British Columbia, May 13, 2022. Lexston Life Sciences Corp. (the “Company” or “Lexston”)

(CSE: LEXT) (OTCQB: LEXTF) announces that its board of directors approve d the consolidation of the

common shares of the Company on the ratio of five (5) pre -consolidated shares for one (1) post -

consolidated share. The effective date and timing of the share consolidation will be d etermined and

announced at a later date.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy

or accuracy of the content of this news release.